Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Stange

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Zeitschrift Fur Gastroenterologie|April 4, 2002
[Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines]E F Stange
Biochemical Society Transactions|April 1, 1987
Compartmentalization of cholesterol in hepatic and intestinal cells: implications for bile and lipoprotein secretionE F Stange
Alimentary Pharmacology & Therapeutics|September 12, 2006
Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel diseaseE F Stange
Der Internist|October 7, 2000
[Evidence-based medicine and quality assurance]E F Stange
MMW Fortschritte Der Medizin|November 21, 2000
[Ulcerative colitis. When is standard therapy enough?]E F Stange
Der Internist|May 1, 1989
[Atherosclerosis in diabetes mellitus]E F Stange
Leber, Magen, Darm|July 1, 1986
[Principles of cholesterol and bile acid metabolism in the liver and small intestine (I)]E F Stange
Der Internist|May 1, 2001
[Chronic inflammatory bowel diseases: drug therapy standards and trends]J Schölmerich, E F Stange
Journal of Hepatology|April 3, 2001
Cholesterol and cholestasis: a lesson from the Mdr2 (-/-) mouseM Fuchs, E F Stange
Deutsche Medizinische Wochenschrift (1946)|September 2, 2011
[Biologicals first-line in chronic inflammatory bowel disease? No]K Herrlinger, E F Stange
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Zeitschrift Fur Gastroenterologie|April 4, 2002
[Chronic inflammatory bowel disease - new therapies: tumor necrosis factor-antibodies and cytokines]E F Stange
Biochemical Society Transactions|April 1, 1987
Compartmentalization of cholesterol in hepatic and intestinal cells: implications for bile and lipoprotein secretionE F Stange
Alimentary Pharmacology & Therapeutics|September 12, 2006
Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel diseaseE F Stange
Der Internist|October 7, 2000
[Evidence-based medicine and quality assurance]E F Stange
MMW Fortschritte Der Medizin|November 21, 2000
[Ulcerative colitis. When is standard therapy enough?]E F Stange
Der Internist|May 1, 1989
[Atherosclerosis in diabetes mellitus]E F Stange
Leber, Magen, Darm|July 1, 1986
[Principles of cholesterol and bile acid metabolism in the liver and small intestine (I)]E F Stange
Der Internist|May 1, 2001
[Chronic inflammatory bowel diseases: drug therapy standards and trends]J Schölmerich, E F Stange
Journal of Hepatology|April 3, 2001
Cholesterol and cholestasis: a lesson from the Mdr2 (-/-) mouseM Fuchs, E F Stange
Deutsche Medizinische Wochenschrift (1946)|September 2, 2011
[Biologicals first-line in chronic inflammatory bowel disease? No]K Herrlinger, E F Stange
Pageof 21